Mindfulness-Based Education For Women With Polycystic Ovary Syndrome
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Polycystic ovary syndrome (PCOS), also known as polyendocrine metabolic ovarian syndrome (PMOS), is the most common endocrinologic disorder to affect women. Despite this, the disease's pathophysiology remains unclear. This has hindered the diagnosis of the disease and the appropriate treatment for millions of individuals. The long-term health sequelae associated with PCOS, future directions, and areas of needed research in this often-overlooked disease. Women with PCOS may experience menstrual symptoms, increased stress, and difficulties in managing the physical and emotional effects of the condition. Supportive approaches that improve symptom management and quality of life may be beneficial in addition to routine care. The aim of this randomized controlled study is to evaluate the effect of mindfulness-based PCOS education on menstrual symptoms, stress levels, and quality of life in women with PCOS. The study will examine whether a structured mindfulness-based education program can support women in managing PCOS-related symptoms and improving their overall well-being. Women diagnosed with PCOS who meet the study eligibility criteria will be invited to participate. Participants will be randomly assigned to either the intervention group or the control group. Participants in the intervention group will receive a mindfulness-based PCOS education program, while those in the control group will receive routine care without it. Researchers will assess participants' menstrual symptoms, stress levels, and quality of life using validated measurement tools before and after the intervention. The findings of this study will provide information about the potential role of mindfulness-based education as a supportive approach in the management of PCOS and may contribute to the development of patient-centered education programs for women with PCOS.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Identyfikować się jako kobieta
- •Mieć od 18 do 49 lat
- •Mieć potwierdzoną diagnozę zespołu policystycznych jajników (PCOS)
- •Posługiwać się językiem tureckim w mowie i piśmie
- •Mieć dostęp do internetu i urządzenia do udziału w zajęciach online
- •Być gotową uczestniczyć w czterotygodniowym programie online i ukończyć wszystkie badania
- •Podpisać świadomą zgodę na udział w badaniu
✗ Disqualifies
- •Być w ciąży lub karmieniu piersią
- •Mieć poważne zaburzenia psychiczne lub problemy z pamięcią
- •Mieć poważne choroby przewlekłe, które mogą wpłynąć na wyniki badania
- •Brać udział w innym badaniu klinicznym
- •Wcześniej ukończyć szkolenie z uważności lub program oparty na uważności
- •Nie móc uczestniczyć w zajęciach online lub ukończyć badania
- •Wycofać zgodę na udział w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 49 Years
- Last updated (source)
- August 21, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Bursa Uludag University obstetrics and gynecology clinic
Bursa, Turkey (Türkiye)
Trial contact
Gonca Buran, Associate Professor
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/22/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.